AllergyTalk Severe Pediatric Asthma Miniseries Episode 3: Beyond Standard Therapy, the Role of Current and Future Therapies Including Biologics
Price: FREE for members and non-members
This episode will examine the role of current and future therapies including biologics for severe pediatric asthma.
Explore additional severe pediatric asthma resources
This podcast series is supported by Sanofi Regeneron.
Gerald Lee, MD is an allergist/immunologist at Children’s Healthcare of Atlanta. Dr. Lee received his medical degree from Case Western Reserve University in 2003. He completed a combined internal medicine/pediatrics residency at Saint Vincent’s Catholic Medical Centers in New York, NY where he was also a pediatric chief resident. He completed his fellowship in allergy/immunology at Cincinnati Children’s Hospital Medical Center in 2011. He is currently an associate professor of pediatrics and internal medicine at the Emory University School of Medicine where he is director of the medical school’s immunology thread and director of the allergy/immunology fellowship. He is an assistant editor for Allergy Watch and co-hosts the ACAAI AllergyTalk podcast.
William S. Anderson III, MD is Associate Professor of Pediatrics at Children’s Hospital Colorado and University of Colorado School of Medicine and board-certified in Pediatrics, Internal Medicine, and Allergy and Immunology. At Children’s Hospital Colorado, Dr. Anderson is the director of the Multidisciplinary Asthma Clinic, co-director of the Improving Pediatric to Adult Care Transition Program, and associated program director for their Allergy and Immunology Fellowship. His clinical and scholarly interests include difficult-to-treat and severe asthma, technology in medicine including electronic medication monitoring, and the transition from pediatric to adult care.
Princess Ogbogu, MD is the Director of the Division of Pediatric Allergy, Immunology, and Rheumatology at University Hospitals Rainbow Babies and Children’s Hospital in Cleveland, Ohio. Dr. Ogbogu completed her residency in Internal Medicine and her subspecialty training in Allergy/Immunology at the National Institutes of Health, in Bethesda Maryland. She serves as a Director of the American Board of Allergy and Immunology and holds leadership positions in several national committees within the American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology. Her clinical and research interests are in eosinophilic disorders and health disparities.